Active • Host: HEK293 cells • AA: 26-390 • Tag: C-terminal human IgG1 Fc • MW: 67.4 kDa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CD4 Extracellular Domain (human, recombinant)

Item No. 31831

Technical Information
Synonyms
  • Cluster of Differentiation 4
  • T Cell Surface Antigen T4
  • T Cell Surface Glycoprotein CD4
Purity
≥95% estimated by SDS-PAGE
Endotoxin Testing
<1.0 EU/µg, determined by the LAL endotoxin assay
Source
Active recombinant C-terminal human IgG1 Fc-tagged CD4 expressed in HEK293 cells
Amino Acids
26-390
MW
67.4 kDa
Lyophilized from sterile PBS, pH 7.4
UniProt Accession №
P01730
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    CD4 is a type I transmembrane glycoprotein that functions as a T cell receptor (TCR) co-receptor.1 It exists as a single polypeptide chain composed of four extracellular immunoglobulin-like (Ig-like) domains that interact with MHC class II molecules, a transmembrane domain, and a cytoplasmic tail that associates with the tyrosine kinase LCK and mediates signal transduction to the TCR, which is essential for T cell activation.2 It is expressed on the surface of, and used as a marker for, T cells, and its expression is used to characterize the development stage of thymocytes. Upon binding to antigen-displaying MHC class II molecules expressed by antigen-presenting cells (APCs), naïve CD4+ T cells differentiate and proliferate in a cytokine-dependent manner into a variety of T helper (Th) cell subsets, including Th1, Th2, and Th17 cells, which enhance and direct innate and adaptive immune cell responses to numerous pathogens and have additional roles in cancer, asthma and allergy, and autoimmunity.3,4 CD4 is also the receptor for HIV attachment and entry into cells, resulting in depletion of CD4+ cells in patients infected with HIV.5,6 Cayman's CD4 Extracellular Domain (human, recombinant) protein can be used for cell-based assay applications. This protein is a disulfide-linked homodimer. The reduced monomer, comprised of CD4 (amino acids 26-390) fused to human IgG1 Fc at its C-terminus, consists of 603 amino acids, has a calculated molecular weight of 67.4 kDa, and a predicted N-terminus of Lys26 after signal peptide cleavage.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Wittlich, M., Koenig, B.W., Hoffmann, S., et alStructural characterization of the transmembrane and cytoplasmic domains of human CD4. Biochim. Biophys. Acta 1768(12), 2949-2960 (2007).

    2. Mak, T.W., and Saunders, M.E. The T cell receptor: Structure of its proteins and genes. The immune response: Basic and clinical principles 311-340 (2006).

    3. Nguyen, Q.P., Deng, T.Z., Witherden, D.A., et alOrigins of CD4+ circulating and tissue-resident memory T-cells. Immunology 157(1), 3-12 (2019).

    4. Zhu, J., and Paul, W.E. CD4 T cells: Fates, functions, and faults. Blood 112(5), 1557-1569 (2008).

    5. Wilen, C.B., Tilton, J.C., and Doms, R.W. HIV: Cell binding and entry. Cold Spring Harb. Perspect. Med. 2(8), a006866 (2012).

    6. Vijayan, K.K.V., Karthigeyan, K.P., Tripathi, S.P., et alPathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections. Front. Immunol. 8, 580 (2017).